🧴 RETATRUTIDE – 20 MG KIT (4 MG / VIAL × 5 VIALS) – ZPHC PHARMA
🧪 Product Type
Peptide / Triple Receptor Agonist
Active Ingredient: Retatrutide
Dosage Form: Lyophilized Powder for Reconstitution
Total Content: 20 MG per kit (5 vials × 4 MG)
Manufacturer: ZPHC PHARMA
📄 Description
RETATRUTIDE 20 MG KIT from ZPHC PHARMA is a cutting-edge investigational peptide engineered to act as a triple agonist, targeting:
- GLP-1 (Glucagon-Like Peptide-1)
- GIP (Gastric Inhibitory Polypeptide)
- Glucagon Receptor
This unique receptor combination is under study for its potent effects on weight loss, metabolic regulation, and glucose control. Retatrutide represents the latest advancement in multi-targeted metabolic therapies, ideal for research into obesity, type 2 diabetes, and energy balance.
✅ Key Features
- 💉 Concentration: 4 MG per vial
- 🧪 Total Kit Strength: 20 MG (5 vials)
- 🔬 Form: Lyophilized powder for subcutaneous injection after reconstitution
- ❄️ Storage: Store refrigerated at 2°C – 8°C after mixing
⚙️ Mechanism of Action
Retatrutide binds to and activates GLP-1, GIP, and glucagon receptors, leading to:
- Reduced appetite and enhanced satiety
- Increased energy expenditure and fat oxidation
- Improved glycemic control via insulin sensitivity
- Potential weight reduction even in resistant obesity models
📈 Research Benefits
- 🔥 Promotes significant fat loss
- 💪 Preserves lean body mass during caloric deficit
- 🧠 May improve mood, cognitive function, and energy levels
- 📉 Reduces blood glucose and insulin resistance markers
- 🧬 Ideal for multi-faceted metabolic research protocols
💉 Suggested Research Use (Laboratory Use Only)
- Reconstitute each vial with bacteriostatic water
- Administer via subcutaneous injection
- Standard experimental doses vary based on subject type and study duration
- Typically dosed once weekly in extended-release trials
⚠️ Possible Side Effects
- Nausea or GI upset
- Decreased appetite
- Headache or fatigue
- Injection site redness
- Dose-dependent effects, often mild and temporary
🚫 Contraindications (For Research Exclusion Criteria)
- Active or past history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Allergy to peptide components
- Use in pregnant or lactating models not advised
🛒 Product Information
- Product Name: Retatrutide 20 MG KIT
- Contents: 5 Vials × 4 MG
- Manufacturer: ZPHC PHARMA
- Use: For Research Purposes Only – Not for Human Consumption
- Shipping: Delivered via trusted research suppliers
- Storage Conditions: Refrigerate post-reconstitution
| Brands | ZPHC PHARMA |